Role of serum concentration of VEGFR1 and TIMP2 on clinical outcome in primary cervical cancer: Results of a companion protocol of the randomized, NOGGO-AGO phase III adjuvant trial of simultaneous cisplatin-based radiochemotherapy vs. carboplatin and pac

► VEGFR1, TIMP2 and MMP2 had impact on surgical outcome in primary cervical cancer. ► VEGFR1 correlated with lymph node status. ► TIMP2 independent prognostic factor for overall survival.